Literature DB >> 19090606

Tuberculosis incidence in elderly in Serbia: key trends in socioeconomic transition.

Dragica P Pesut1, Zorana B Gledović, Anita D Grgurević, Ljudmila M Nagorni-Obradović, Tatjana N Adzić.   

Abstract

AIM: To examine tuberculosis incidence rates among the elderly in Central Serbia in 1992-2006 period, which was characterized by socioeconomic crisis and migration of population.
METHODS: We analyzed all reported active tuberculosis cases in a 15-year period, especially among patients aged > or =65, according to the Annual Reports of the Institute of Lung Diseases and Tuberculosis in Belgrade and Central Tuberculosis Register. Population estimates with extrapolations were based on 1991 and 2002 census data.
RESULTS: Total tuberculosis incidence rates showed a slight but non-significant decreasing trend (P=0.535), and no significant increase was found in patients aged > or =65 years (P=0.064), with an average age-specific incidence rate for the elderly of 64.0 (95% confidence interval, 60.7-67.4). The increase was significant in patients aged > or =70 years (y=49.3549+2.1186x; P=0.001), both in men (y=62.8666+2.3977x; P=0.005) and even more prominently in women (y=39.8240+1.9150x; P<0.001). The proportion of tuberculosis cases in the elderly peaked in 2005, with 35% of all tuberculosis cases.
CONCLUSION: High incidence rates and increasing time trend of tuberculosis in the elderly in Central Serbia is a serious problem, especially among those aged 70 years and over, who might present a target group for active case-finding of the disease.

Entities:  

Mesh:

Year:  2008        PMID: 19090606      PMCID: PMC2621029          DOI: 10.3325/cmj.2008.49.807

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  14 in total

Review 1.  Risk factors for tuberculosis.

Authors:  P D O Davies
Journal:  Monaldi Arch Chest Dis       Date:  2005-03

2.  Burden of tuberculosis in Serbia.

Authors:  Zorana Gledovic; Hristina Vlajinac; Tatjana Pekmezovic; Sandra Grujicic-Sipetic; Anita Grgurevic; Dragica Pesut
Journal:  Am J Infect Control       Date:  2006-12       Impact factor: 2.918

3.  Microepidemics of tuberculosis: the stone-in-the-pond principle.

Authors:  J Veen
Journal:  Tuber Lung Dis       Date:  1992-04

4.  TB in the elderly in industrialised countries.

Authors:  Peter D O Davies
Journal:  Int J Tuberc Lung Dis       Date:  2007-11       Impact factor: 2.373

5.  TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course.

Authors:  Christian Wejse; Per Gustafson; Jens Nielsen; Victor Francisco Gomes; Peter Aaby; Paul Lehm Andersen; Morten Sodemann
Journal:  Scand J Infect Dis       Date:  2008

6.  Long-term trends in tuberculosis. Comparison of age-cohort data between Hong Kong and England and Wales.

Authors:  K Tocque; M A Bellis; C M Tam; S L Chan; Q Syed; T Remmington; P D Davies
Journal:  Am J Respir Crit Care Med       Date:  1998-08       Impact factor: 21.405

7.  [Active case detection for tuberculosis in risk groups in Serbia].

Authors:  Dragica Pesut
Journal:  Med Pregl       Date:  2004

8.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

Authors:  M C Raviglione; D E Snider; A Kochi
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

9.  Epidemiology of tuberculosis in the United States, 1985 through 1992.

Authors:  M F Cantwell; D E Snider; G M Cauthen; I M Onorato
Journal:  JAMA       Date:  1994-08-17       Impact factor: 56.272

10.  Mortality of Roma population in Serbia, 2002-2005.

Authors:  Dragan Bogdanović; Dragana Nikić; Branislav Petrović; Biljana Kocić; Jovica Jovanović; Maja Nikolić; Zoran Milosević
Journal:  Croat Med J       Date:  2007-10       Impact factor: 1.351

View more
  1 in total

1.  Gender disparities in mortality from infectious diseases in Serbia, 1991-2014: a time of civil wars and global crisis.

Authors:  M Ilic; I Ilic
Journal:  Epidemiol Infect       Date:  2016-09       Impact factor: 4.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.